Aryx Therapeutics Beta vs. Current Liabilities

ARYX
 Stock
  

USD 0.0005  0.00  0.00%   

For Aryx Therapeutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Aryx Therapeutics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Aryx Therapeutics I utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Aryx Therapeutics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Aryx Therapeutics I over time as well as its relative position and ranking within its peers. Please continue to Trending Equities.
  
Please note, there is a significant difference between Aryx Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine Aryx Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aryx Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Aryx Therapeutics Current Liabilities vs. Beta Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Aryx Therapeutics's current stock value. Our valuation model uses many indicators to compare Aryx Therapeutics value to that of its competitors to determine the firm's financial worth.
Aryx Therapeutics I is number one stock in beta category among related companies. It is rated third in current liabilities category among related companies . . Comparative valuation analysis is a catch-all model that can be used if you cannot value Aryx Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Aryx Therapeutics' OTC Pink Sheet . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Aryx Therapeutics' earnings, one of the primary drivers of an investment's value.

Aryx Therapeutics Current Liabilities vs. Beta

Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it will be expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Aryx Therapeutics 
Beta 
 = 
Covariance 
Variance 
-0.15
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Aryx Therapeutics 
Current Liabilities 
 = 
Payables 
Accrued Debt 
8.49 M
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.

Aryx Therapeutics Current Liabilities Comparison

Aryx Therapeutics is currently under evaluation in current liabilities category among related companies.

Beta Analysis

Let's try to break down what Aryx Therapeutics's beta means in this case. As returns on the market increase, returns on owning Aryx Therapeutics are expected to decrease at a much lower rate. During the bear market, Aryx Therapeutics is likely to outperform the market.

Aryx Therapeutics Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Aryx Therapeutics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Aryx Therapeutics will eventually generate negative long term returns. The profitability progress is the general direction of Aryx Therapeutics' change in net profit over the period of time. It can combine multiple indicators of Aryx Therapeutics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
ARYx Therapeutics, Inc. discovers and develops novel therapies for large, chronic, and oral markets. ARYx Therapeutics, Inc. was founded in 1997 and is based in Fremont, California. ARYX THERAPEUTICS operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on PNK Exchange. It employs 56 people.

Aryx Therapeutics Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Aryx Therapeutics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Aryx Therapeutics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Aryx Therapeutics' important profitability drivers and their relationship over time.

Use Aryx Therapeutics in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aryx Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aryx Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Aryx Therapeutics Pair Trading

Aryx Therapeutics I Pair Trading Analysis

The ability to find closely correlated positions to Aryx Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aryx Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aryx Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aryx Therapeutics I to buy it.
The correlation of Aryx Therapeutics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aryx Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aryx Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aryx Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Aryx Therapeutics position

In addition to having Aryx Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Cigarettes Thematic Idea Now

Cigarettes
Cigarettes Theme
Tobacco makers and distributors across globe. The Cigarettes theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cigarettes Theme or any other thematic opportunities.
View All  Next Launch
Please continue to Trending Equities. You can also try Stock Screener module to find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Complementary Tools for analysis

When running Aryx Therapeutics price analysis, check to measure Aryx Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aryx Therapeutics is operating at the current time. Most of Aryx Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aryx Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Aryx Therapeutics' price. Additionally, you may evaluate how the addition of Aryx Therapeutics to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
To fully project Aryx Therapeutics' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Aryx Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Aryx Therapeutics' income statement, its balance sheet, and the statement of cash flows.
Potential Aryx Therapeutics investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Aryx Therapeutics investors may work on each financial statement separately, they are all related. The changes in Aryx Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Aryx Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.